AbbVie’s Humira slowed its TV ad spending by almost 40% in December, but it still wasn't quite enough to drop out of the top spot. Humira spending for the month totaled $23 million, down from almost $38 million in November, and AbbVie also decreased the number of ads it ran; it's now down to four different commercials across its three indications.
